0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Validation Services Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-30E12333
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Validation Services Market Research Report 2022
BUY CHAPTERS

Global Pharmaceutical Validation Services Market Research Report 2025

Code: QYRE-Auto-30E12333
Report
March 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical Validation Services Market Size

The global market for Pharmaceutical Validation Services was valued at US$ 103 million in the year 2024 and is projected to reach a revised size of US$ 147 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Pharmaceutical Validation Services Market

Pharmaceutical Validation Services Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Validation Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Validation Services.
The Pharmaceutical Validation Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Validation Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Validation Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmaceutical Validation Services Market Report

Report Metric Details
Report Name Pharmaceutical Validation Services Market
Accounted market size in year US$ 103 million
Forecasted market size in 2031 US$ 147 million
CAGR 5.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Pharmaceutical Cleaning Validation Services
  • Pharmaceutical Equipment Validation Services
  • Others
Segment by Application
  • Pharmaceutical Companies
  • Biotechnological Companies
  • Academic and Research Institutes
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Arbor Group, ATS Global, Catalent, CRS Pharma Solutions, Eurofins Scientific, Körber Pharma, Merck Millipore, MTS (Meissner Technical Services), Navitas pharma READY, PharmOut, SGS, Sigma-Aldrich, SL Controls, Transcat
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmaceutical Validation Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pharmaceutical Validation Services Market growing?

Ans: The Pharmaceutical Validation Services Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Pharmaceutical Validation Services Market size in 2031?

Ans: The Pharmaceutical Validation Services Market size in 2031 will be US$ 147 million.

Who are the main players in the Pharmaceutical Validation Services Market report?

Ans: The main players in the Pharmaceutical Validation Services Market are Arbor Group, ATS Global, Catalent, CRS Pharma Solutions, Eurofins Scientific, Körber Pharma, Merck Millipore, MTS (Meissner Technical Services), Navitas pharma READY, PharmOut, SGS, Sigma-Aldrich, SL Controls, Transcat

What are the Application segmentation covered in the Pharmaceutical Validation Services Market report?

Ans: The Applications covered in the Pharmaceutical Validation Services Market report are Pharmaceutical Companies, Biotechnological Companies, Academic and Research Institutes

What are the Type segmentation covered in the Pharmaceutical Validation Services Market report?

Ans: The Types covered in the Pharmaceutical Validation Services Market report are Pharmaceutical Cleaning Validation Services, Pharmaceutical Equipment Validation Services, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Validation Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pharmaceutical Cleaning Validation Services
1.2.3 Pharmaceutical Equipment Validation Services
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical Validation Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnological Companies
1.3.4 Academic and Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Validation Services Market Perspective (2020-2031)
2.2 Global Pharmaceutical Validation Services Growth Trends by Region
2.2.1 Global Pharmaceutical Validation Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Validation Services Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical Validation Services Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical Validation Services Market Dynamics
2.3.1 Pharmaceutical Validation Services Industry Trends
2.3.2 Pharmaceutical Validation Services Market Drivers
2.3.3 Pharmaceutical Validation Services Market Challenges
2.3.4 Pharmaceutical Validation Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Validation Services Players by Revenue
3.1.1 Global Top Pharmaceutical Validation Services Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Validation Services Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical Validation Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Validation Services Revenue
3.4 Global Pharmaceutical Validation Services Market Concentration Ratio
3.4.1 Global Pharmaceutical Validation Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Validation Services Revenue in 2024
3.5 Global Key Players of Pharmaceutical Validation Services Head office and Area Served
3.6 Global Key Players of Pharmaceutical Validation Services, Product and Application
3.7 Global Key Players of Pharmaceutical Validation Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Validation Services Breakdown Data by Type
4.1 Global Pharmaceutical Validation Services Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical Validation Services Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical Validation Services Breakdown Data by Application
5.1 Global Pharmaceutical Validation Services Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical Validation Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Validation Services Market Size (2020-2031)
6.2 North America Pharmaceutical Validation Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Validation Services Market Size by Country (2020-2025)
6.4 North America Pharmaceutical Validation Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Validation Services Market Size (2020-2031)
7.2 Europe Pharmaceutical Validation Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Validation Services Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical Validation Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Validation Services Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Validation Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Validation Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Validation Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Validation Services Market Size (2020-2031)
9.2 Latin America Pharmaceutical Validation Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Validation Services Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Validation Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Validation Services Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Validation Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Validation Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Validation Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arbor Group
11.1.1 Arbor Group Company Details
11.1.2 Arbor Group Business Overview
11.1.3 Arbor Group Pharmaceutical Validation Services Introduction
11.1.4 Arbor Group Revenue in Pharmaceutical Validation Services Business (2020-2025)
11.1.5 Arbor Group Recent Development
11.2 ATS Global
11.2.1 ATS Global Company Details
11.2.2 ATS Global Business Overview
11.2.3 ATS Global Pharmaceutical Validation Services Introduction
11.2.4 ATS Global Revenue in Pharmaceutical Validation Services Business (2020-2025)
11.2.5 ATS Global Recent Development
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent Pharmaceutical Validation Services Introduction
11.3.4 Catalent Revenue in Pharmaceutical Validation Services Business (2020-2025)
11.3.5 Catalent Recent Development
11.4 CRS Pharma Solutions
11.4.1 CRS Pharma Solutions Company Details
11.4.2 CRS Pharma Solutions Business Overview
11.4.3 CRS Pharma Solutions Pharmaceutical Validation Services Introduction
11.4.4 CRS Pharma Solutions Revenue in Pharmaceutical Validation Services Business (2020-2025)
11.4.5 CRS Pharma Solutions Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Pharmaceutical Validation Services Introduction
11.5.4 Eurofins Scientific Revenue in Pharmaceutical Validation Services Business (2020-2025)
11.5.5 Eurofins Scientific Recent Development
11.6 Körber Pharma
11.6.1 Körber Pharma Company Details
11.6.2 Körber Pharma Business Overview
11.6.3 Körber Pharma Pharmaceutical Validation Services Introduction
11.6.4 Körber Pharma Revenue in Pharmaceutical Validation Services Business (2020-2025)
11.6.5 Körber Pharma Recent Development
11.7 Merck Millipore
11.7.1 Merck Millipore Company Details
11.7.2 Merck Millipore Business Overview
11.7.3 Merck Millipore Pharmaceutical Validation Services Introduction
11.7.4 Merck Millipore Revenue in Pharmaceutical Validation Services Business (2020-2025)
11.7.5 Merck Millipore Recent Development
11.8 MTS (Meissner Technical Services)
11.8.1 MTS (Meissner Technical Services) Company Details
11.8.2 MTS (Meissner Technical Services) Business Overview
11.8.3 MTS (Meissner Technical Services) Pharmaceutical Validation Services Introduction
11.8.4 MTS (Meissner Technical Services) Revenue in Pharmaceutical Validation Services Business (2020-2025)
11.8.5 MTS (Meissner Technical Services) Recent Development
11.9 Navitas pharma READY
11.9.1 Navitas pharma READY Company Details
11.9.2 Navitas pharma READY Business Overview
11.9.3 Navitas pharma READY Pharmaceutical Validation Services Introduction
11.9.4 Navitas pharma READY Revenue in Pharmaceutical Validation Services Business (2020-2025)
11.9.5 Navitas pharma READY Recent Development
11.10 PharmOut
11.10.1 PharmOut Company Details
11.10.2 PharmOut Business Overview
11.10.3 PharmOut Pharmaceutical Validation Services Introduction
11.10.4 PharmOut Revenue in Pharmaceutical Validation Services Business (2020-2025)
11.10.5 PharmOut Recent Development
11.11 SGS
11.11.1 SGS Company Details
11.11.2 SGS Business Overview
11.11.3 SGS Pharmaceutical Validation Services Introduction
11.11.4 SGS Revenue in Pharmaceutical Validation Services Business (2020-2025)
11.11.5 SGS Recent Development
11.12 Sigma-Aldrich
11.12.1 Sigma-Aldrich Company Details
11.12.2 Sigma-Aldrich Business Overview
11.12.3 Sigma-Aldrich Pharmaceutical Validation Services Introduction
11.12.4 Sigma-Aldrich Revenue in Pharmaceutical Validation Services Business (2020-2025)
11.12.5 Sigma-Aldrich Recent Development
11.13 SL Controls
11.13.1 SL Controls Company Details
11.13.2 SL Controls Business Overview
11.13.3 SL Controls Pharmaceutical Validation Services Introduction
11.13.4 SL Controls Revenue in Pharmaceutical Validation Services Business (2020-2025)
11.13.5 SL Controls Recent Development
11.14 Transcat
11.14.1 Transcat Company Details
11.14.2 Transcat Business Overview
11.14.3 Transcat Pharmaceutical Validation Services Introduction
11.14.4 Transcat Revenue in Pharmaceutical Validation Services Business (2020-2025)
11.14.5 Transcat Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pharmaceutical Validation Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Pharmaceutical Cleaning Validation Services
 Table 3. Key Players of Pharmaceutical Equipment Validation Services
 Table 4. Key Players of Others
 Table 5. Global Pharmaceutical Validation Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharmaceutical Validation Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Pharmaceutical Validation Services Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Pharmaceutical Validation Services Market Share by Region (2020-2025)
 Table 9. Global Pharmaceutical Validation Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Pharmaceutical Validation Services Market Share by Region (2026-2031)
 Table 11. Pharmaceutical Validation Services Market Trends
 Table 12. Pharmaceutical Validation Services Market Drivers
 Table 13. Pharmaceutical Validation Services Market Challenges
 Table 14. Pharmaceutical Validation Services Market Restraints
 Table 15. Global Pharmaceutical Validation Services Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Pharmaceutical Validation Services Market Share by Players (2020-2025)
 Table 17. Global Top Pharmaceutical Validation Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Validation Services as of 2024)
 Table 18. Ranking of Global Top Pharmaceutical Validation Services Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Pharmaceutical Validation Services Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Pharmaceutical Validation Services, Headquarters and Area Served
 Table 21. Global Key Players of Pharmaceutical Validation Services, Product and Application
 Table 22. Global Key Players of Pharmaceutical Validation Services, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Pharmaceutical Validation Services Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Pharmaceutical Validation Services Revenue Market Share by Type (2020-2025)
 Table 26. Global Pharmaceutical Validation Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Pharmaceutical Validation Services Revenue Market Share by Type (2026-2031)
 Table 28. Global Pharmaceutical Validation Services Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Pharmaceutical Validation Services Revenue Market Share by Application (2020-2025)
 Table 30. Global Pharmaceutical Validation Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Pharmaceutical Validation Services Revenue Market Share by Application (2026-2031)
 Table 32. North America Pharmaceutical Validation Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Pharmaceutical Validation Services Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Pharmaceutical Validation Services Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Pharmaceutical Validation Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Pharmaceutical Validation Services Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Pharmaceutical Validation Services Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Pharmaceutical Validation Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Pharmaceutical Validation Services Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Pharmaceutical Validation Services Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Pharmaceutical Validation Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Pharmaceutical Validation Services Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Pharmaceutical Validation Services Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Pharmaceutical Validation Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Pharmaceutical Validation Services Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Pharmaceutical Validation Services Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Arbor Group Company Details
 Table 48. Arbor Group Business Overview
 Table 49. Arbor Group Pharmaceutical Validation Services Product
 Table 50. Arbor Group Revenue in Pharmaceutical Validation Services Business (2020-2025) & (US$ Million)
 Table 51. Arbor Group Recent Development
 Table 52. ATS Global Company Details
 Table 53. ATS Global Business Overview
 Table 54. ATS Global Pharmaceutical Validation Services Product
 Table 55. ATS Global Revenue in Pharmaceutical Validation Services Business (2020-2025) & (US$ Million)
 Table 56. ATS Global Recent Development
 Table 57. Catalent Company Details
 Table 58. Catalent Business Overview
 Table 59. Catalent Pharmaceutical Validation Services Product
 Table 60. Catalent Revenue in Pharmaceutical Validation Services Business (2020-2025) & (US$ Million)
 Table 61. Catalent Recent Development
 Table 62. CRS Pharma Solutions Company Details
 Table 63. CRS Pharma Solutions Business Overview
 Table 64. CRS Pharma Solutions Pharmaceutical Validation Services Product
 Table 65. CRS Pharma Solutions Revenue in Pharmaceutical Validation Services Business (2020-2025) & (US$ Million)
 Table 66. CRS Pharma Solutions Recent Development
 Table 67. Eurofins Scientific Company Details
 Table 68. Eurofins Scientific Business Overview
 Table 69. Eurofins Scientific Pharmaceutical Validation Services Product
 Table 70. Eurofins Scientific Revenue in Pharmaceutical Validation Services Business (2020-2025) & (US$ Million)
 Table 71. Eurofins Scientific Recent Development
 Table 72. Körber Pharma Company Details
 Table 73. Körber Pharma Business Overview
 Table 74. Körber Pharma Pharmaceutical Validation Services Product
 Table 75. Körber Pharma Revenue in Pharmaceutical Validation Services Business (2020-2025) & (US$ Million)
 Table 76. Körber Pharma Recent Development
 Table 77. Merck Millipore Company Details
 Table 78. Merck Millipore Business Overview
 Table 79. Merck Millipore Pharmaceutical Validation Services Product
 Table 80. Merck Millipore Revenue in Pharmaceutical Validation Services Business (2020-2025) & (US$ Million)
 Table 81. Merck Millipore Recent Development
 Table 82. MTS (Meissner Technical Services) Company Details
 Table 83. MTS (Meissner Technical Services) Business Overview
 Table 84. MTS (Meissner Technical Services) Pharmaceutical Validation Services Product
 Table 85. MTS (Meissner Technical Services) Revenue in Pharmaceutical Validation Services Business (2020-2025) & (US$ Million)
 Table 86. MTS (Meissner Technical Services) Recent Development
 Table 87. Navitas pharma READY Company Details
 Table 88. Navitas pharma READY Business Overview
 Table 89. Navitas pharma READY Pharmaceutical Validation Services Product
 Table 90. Navitas pharma READY Revenue in Pharmaceutical Validation Services Business (2020-2025) & (US$ Million)
 Table 91. Navitas pharma READY Recent Development
 Table 92. PharmOut Company Details
 Table 93. PharmOut Business Overview
 Table 94. PharmOut Pharmaceutical Validation Services Product
 Table 95. PharmOut Revenue in Pharmaceutical Validation Services Business (2020-2025) & (US$ Million)
 Table 96. PharmOut Recent Development
 Table 97. SGS Company Details
 Table 98. SGS Business Overview
 Table 99. SGS Pharmaceutical Validation Services Product
 Table 100. SGS Revenue in Pharmaceutical Validation Services Business (2020-2025) & (US$ Million)
 Table 101. SGS Recent Development
 Table 102. Sigma-Aldrich Company Details
 Table 103. Sigma-Aldrich Business Overview
 Table 104. Sigma-Aldrich Pharmaceutical Validation Services Product
 Table 105. Sigma-Aldrich Revenue in Pharmaceutical Validation Services Business (2020-2025) & (US$ Million)
 Table 106. Sigma-Aldrich Recent Development
 Table 107. SL Controls Company Details
 Table 108. SL Controls Business Overview
 Table 109. SL Controls Pharmaceutical Validation Services Product
 Table 110. SL Controls Revenue in Pharmaceutical Validation Services Business (2020-2025) & (US$ Million)
 Table 111. SL Controls Recent Development
 Table 112. Transcat Company Details
 Table 113. Transcat Business Overview
 Table 114. Transcat Pharmaceutical Validation Services Product
 Table 115. Transcat Revenue in Pharmaceutical Validation Services Business (2020-2025) & (US$ Million)
 Table 116. Transcat Recent Development
 Table 117. Research Programs/Design for This Report
 Table 118. Key Data Information from Secondary Sources
 Table 119. Key Data Information from Primary Sources
 Table 120. Authors List of This Report


List of Figures
 Figure 1. Pharmaceutical Validation Services Picture
 Figure 2. Global Pharmaceutical Validation Services Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceutical Validation Services Market Share by Type: 2024 VS 2031
 Figure 4. Pharmaceutical Cleaning Validation Services Features
 Figure 5. Pharmaceutical Equipment Validation Services Features
 Figure 6. Others Features
 Figure 7. Global Pharmaceutical Validation Services Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Pharmaceutical Validation Services Market Share by Application: 2024 VS 2031
 Figure 9. Pharmaceutical Companies Case Studies
 Figure 10. Biotechnological Companies Case Studies
 Figure 11. Academic and Research Institutes Case Studies
 Figure 12. Pharmaceutical Validation Services Report Years Considered
 Figure 13. Global Pharmaceutical Validation Services Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Pharmaceutical Validation Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pharmaceutical Validation Services Market Share by Region: 2024 VS 2031
 Figure 16. Global Pharmaceutical Validation Services Market Share by Players in 2024
 Figure 17. Global Top Pharmaceutical Validation Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Validation Services as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutical Validation Services Revenue in 2024
 Figure 19. North America Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Pharmaceutical Validation Services Market Share by Country (2020-2031)
 Figure 21. United States Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pharmaceutical Validation Services Market Share by Country (2020-2031)
 Figure 25. Germany Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pharmaceutical Validation Services Market Share by Region (2020-2031)
 Figure 33. China Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pharmaceutical Validation Services Market Share by Country (2020-2031)
 Figure 41. Mexico Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pharmaceutical Validation Services Market Share by Country (2020-2031)
 Figure 45. Turkey Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Pharmaceutical Validation Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Arbor Group Revenue Growth Rate in Pharmaceutical Validation Services Business (2020-2025)
 Figure 49. ATS Global Revenue Growth Rate in Pharmaceutical Validation Services Business (2020-2025)
 Figure 50. Catalent Revenue Growth Rate in Pharmaceutical Validation Services Business (2020-2025)
 Figure 51. CRS Pharma Solutions Revenue Growth Rate in Pharmaceutical Validation Services Business (2020-2025)
 Figure 52. Eurofins Scientific Revenue Growth Rate in Pharmaceutical Validation Services Business (2020-2025)
 Figure 53. Körber Pharma Revenue Growth Rate in Pharmaceutical Validation Services Business (2020-2025)
 Figure 54. Merck Millipore Revenue Growth Rate in Pharmaceutical Validation Services Business (2020-2025)
 Figure 55. MTS (Meissner Technical Services) Revenue Growth Rate in Pharmaceutical Validation Services Business (2020-2025)
 Figure 56. Navitas pharma READY Revenue Growth Rate in Pharmaceutical Validation Services Business (2020-2025)
 Figure 57. PharmOut Revenue Growth Rate in Pharmaceutical Validation Services Business (2020-2025)
 Figure 58. SGS Revenue Growth Rate in Pharmaceutical Validation Services Business (2020-2025)
 Figure 59. Sigma-Aldrich Revenue Growth Rate in Pharmaceutical Validation Services Business (2020-2025)
 Figure 60. SL Controls Revenue Growth Rate in Pharmaceutical Validation Services Business (2020-2025)
 Figure 61. Transcat Revenue Growth Rate in Pharmaceutical Validation Services Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

RELATED REPORTS

Global Enhanced Hollow-Fiber Membrane Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T19555
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Disposable Wave Bioreactor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30T17927
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Loperamide Hydrochloride Capsules Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18L19449
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Add to Cart